[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"ba469621231cf93500e6b95241365c9041e9fb8dc983b82c368eba4e6c0a1a3d","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"ba469621231cf93500e6b95241365c9041e9fb8dc983b82c368eba4e6c0a1a3d","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"09ea9d7ea23a231c29bb193a47cb06bc33272c4ad951061e103288420d1c4d84","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"9876a0082aa00e2f8435fb0b9367ecf3f9969fb76f261afd703bd79423ec5dd2","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Describe the phases of drug development from target discovery to investigational new drug (IND) submission and the different functional areas involved.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Explain how target pharmacology and drug safety are assessed using both in vitro and in vivo preclinical models.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Explain the chemistry, manufacturing, and controls (CMC) activities that take place during discovery and preclinical development.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Apply the knowledge learned throughout the course to address specific drug development challenges and propose novel solutions.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Evaluate how preclinical development might differ between small molecule drugs and protein therapeutics.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Create a preclinical drug development strategy for a specific drug modality and disease combination.\"}]"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"4e69a8e8966db95e12ea2c7f39c21ccbfe9f4552fbfa7509b4fe6bd1c37680bd","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"4e69a8e8966db95e12ea2c7f39c21ccbfe9f4552fbfa7509b4fe6bd1c37680bd","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"62f49e8b51b38de3c61f8778612298e336f2817ac3cffd32875c261ec8f42fd6","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"623d2e4561dcce4bcf26cc8fd9d6180c5d86c19bf42b46c6f89148ab2f307974","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"c3e396189286a637f6e827edb6bf011011c565643643134e3ae1869fd43238aa","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"e0b83c38cd8e8ba77eabcd28cb57b8505a2399b63ae791fb604b51764b774ff8","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"59b41a2dfd56f61d0d970062f03b896956ea205168e6788a70b657bf64d960db","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"4a65927333571408cd86c2a942c0cef8333a84118657fa16f9ec4e27f5c86b19","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"f21c20ed65cee3050973b1937ae7645738d0f60b2ee1013915b543ad7f0b10e9","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"85901bfb0cee0827054ca590f1b87376afa39582039a855664acbb04d0f1c424","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"dbfd330926a244778b1650e952344682dfdbc5951fe0b069dcccd3520160f608","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"e45a4ccb9a4e5876800b4a5ca0f2098621c70ad9def75842f8ece3350d84881c","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"30d4fda91099dd00adedad379bab1115e3c5a94fce0efe3c9f10151d9ce34577","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"98486204b816a19564616668bcdaafff75d31a54f9ec1e74f2785950eca822bf","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"7b0249f33a4c2febef777fa310404ba98059c8bcfd8ad766db4eb6b00ab23553","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"157f0b05a6e29fb7c2f2b2c92836a7333b206c1ce79551c724b6212a27714f41","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"45851666f215b03184165c3f745d04de7ba65693ec7b6d062badd364803f086f","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"7eeee66c791a38a921f088b4407ce24cff0c77567c432e64ac168e86063d7bb2","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"fad8c08d41d659b351b612b14a1e3a1ba8ba06711a2a5f2b2658d35241b9060e","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"53c30653576dcff41aea24a6946261c521b28fd44a9c252abced3b0a743d0d57","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"9239021b7d9860d8fe667ed02dec2f522b020f4f58b3516b60734352aa4e1e20","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"9103c4a03c6d951948bc3239531401fefc87fad21258c49b08dcfa0110c7ebe7","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"1529a79350f41e38a77e845cc47e2ea71f858cf47f6c6488e0a6ab159021a23b","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"86774ef237c90ffa53ddca894cdd46da7b083e62bead3bdec1e961180cbb2c5d","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"4b686293a2a3c84055a7a0760b369281326b98699bbfdb9eb4238de3e7ef4e25","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"ad3a7376524ad9076aa9d7a718f8624255dc117eac25e7cbeb015361023413e0","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"ab193766f1d59357f2323489a7b680d322d85b6484d6bb0e71ef25f0fc2bbdca","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"5069806c7b61465f2d09aabab7db7f13b7bb2e4d809c3012195817354889abc9","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"8bdecd6b43d65102d5ca4833387b3b976ca48d3c7cec7b01932f95ccefd2af87","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"a9ea69abe48baba928c39b4faae9e0997c40943ff4055b094a42de569976e56b","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"3c3c19590b4a721196c112c3f302b3a44c22ac73f4b0b78eb512f28c1244ae7c","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"67c90bd89d2946435f609e68681b0d7e815ea99d81e38243d109110c409ba461","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"39a458269c20fee1d39d6511a52d510863a027fbb08b0ace5cce74ca57ddc304","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"c005397b1062b914fe1dc41a4c8f16cf2136fd2708fda64999e3ed5ba7bfa429","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"bc90c69a1f256e11ab06dd1e9fcdede842416d8fda08f0bd7d5bda2e72e18e41","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"7448085beb99ce23fde83cd3e5fcef823e90bd2b3d563d9f5aa1e9050baa1544","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"10f40c799a140e935f9f690b224ed523ce9a8ae0a9b31d9d1ec56e1a36731856","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"32957aeb5767d5805650cadcdff011cda28001f6170759a8397f6fb9496f1b5f","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"2f67177b84a3c68cb8b523aafb7d1ca8a305bc5bf604d6f21103a05a99265e6b","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"e1ee49484d1c6566e99c919564b8f05e9d7d3d826349dfc63ad39484a7cbd880","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"cd75c0c0a578d4e352c83c780b6a6ef8e0e2eefebe02680cf31ae52d2c8b7954","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"36928679009c80a42b0dfbaf84641f31886d79c6ba3cb2116058e2b1b78c4e01","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"801eda7f91f72b97336660bde1fd8102cc6acb1ebb08f059dcec3ff7047558cc","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"ca2913698bb93353ae53de9530d352707cc694471b322a3ed62101f39d57edff","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"f3da98e695f8e0509203c79529ecbb110317b237e3f8740554ae3bdfa30ed005","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"1a46b2a8ff4c3b122f8fe37e9555f71604110cf39c627e3a933e823ceea82af2","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"6be3c80177872d51209f2f06b2c8584d421ea9abfb8dc2bc11224071a31ffe57","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"35e2f6a2f0652a831fda249bef9eed278e90a5ee61c2d6f9db7590a05640c142","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"340066b49ed2d3044ecfdcf7b23884aaf22b3fbe31fa91dc197e08470bdd0916","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"614478615f341c2af5db08f9641d14e2956a51c818f72d53d55cbf13eea73a43","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"5b095de6dfcf6e1318994b27046ca17ab59dda00bad31a12620601e4b68b38ca","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"3d8cd14eeea1b44fa7a12eaa8c57acb8e61e66e82476f89e0632a3c2b25c5f97","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"cecc9f61f44657862ef5bd30b969ed3b0d320f09c89888138700679acd86bfbc","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"65a755a9877f26d4195a799d0b061ff80a1b3ead338140d2399e8c80a89b78a0","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"eb82b082ce32e682dac339ae2778b2149da902f0ab19c2b284e98631ffad1939","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"ac5f67cf973390b49bde0df97b8b05f54913f56572f9260ab65da0594dc9e059","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"f859192bd59d5a26f691fe32a86a2648557e2e28e35876b30d909d8735a275c0","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"25fa7ed8d384551b4a7dc70614cda962256963ac0ac6700d409603284f7d04bd","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"28d4837fadefedb8d23a952bcdddff4b9bb7a3debba348fc1192b30c3a0afb29","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"dc896c38bc6cc4b0f1308c696e7821c50244b33bd8f4be48ff620f243ec76c9c","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"2eeb7d4c41f8c5904b91e82453d30a76c0adde2c5cf1540b1c0f3d55c2ff06f6","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"b362f2362865bf50dd541528d07925c5a815589911781389255871d9d7e16ca1","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"533b47875f0d12c7caef8b61326528e4cd84110861894472896b0d5d387c3c5d","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"c6e9f02e5c46e398d115c263dc7551cf756beef7d12dbbeaf2b22f56d8b21619","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"f3da98e695f8e0509203c79529ecbb110317b237e3f8740554ae3bdfa30ed005","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"b6922899a88233548bc29b9f0eebac4790e1d6d80bd0077904c6994b9fd3bd9e","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"f465e7133ceefd72e657efe6c72134d1f80fab6a8695f52db51eeb48c56bce8c","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"9f379c64d4475defe250fade1ac0e5aedcb1bde1de15e902a8ada804aa238df6","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"31407b4231cce9a503feae8ef018da3eed2c81ef15b4212419dc990e100c4392","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"c44b8bba94d829a163e607ff7438d944aabf764cd12632f3dcb7734d2d83a66e","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"375c395dbb193f98d7521e01e4eca9013fcc5023cdff8bea418d3f5a22275e91","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"654ec029d6eb132bf3d8003eb115dcc7bcfbc0e01449ded75a89199f468b11c8","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"8eb1aff0ccfbc53b75ce922780ecc14e7e9e977199ac2eadcdc97c4743fd5b5a","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"a48439e02fd60f2394dcd50878e0e9f870129921ab17c021f50caa10e095dd19","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"63965cf8f290e907ac04c065cc42ed4dbfffb4f9d611dca5d50b679fe89fa047","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"5d65a98cd9c7a65826fe4dfee69325ffffc28a60d6d4171544e7dae791cedf7d","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"1622766328250d433a559254d88771f35e0331b378dbfc0bb7cca3ad17e2b33f","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"81001c5e9902933f40bab3bd791c5a4d82f5b05c01ffd7fe07655f631b0f060f","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"031722b62507d55b84409a639bde989563887e58fca93304668d6902c0bd4ad8","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"52c2f94a041e15ffa18eaac63614da49754b034b5ee6b53cb7149dbc39ff9e59","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"92064e99f2ec850a7497621bb8f768352d4989b73f52a3e38a3cb997588f7ab7","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"2d8fdd4e69ce66489ce33ce3fd647fe100277780146c4375bc689bba8665c3a0","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)","description":"Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"d847e2782fb94564fbfc1d630ec11cd323308496d407465dfbdb5599899b6a29","course_id":"PHMSCI 762","course_uid":"course_1d5bb2f15f5fd3f6e4e8f809","catalog_version_id":"4993ef41a5670b21384e94ed816504c6d206127e73520a42ea75652bc2649192","course_number":762,"subjects":["PHMSCI"],"title":"THE DRUG DEVELOPMENT PROCESS I","description":"Overview of the drug development process from discovery to approval. Process of drug development from target identification to investigational new drug (IND) submission including tenets of rational drug design, preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies. Small and large molecules (biologics/biotherapeutics) will be covered. Brief history of drug development and various case studies offering insights into preclinical drug development.","requirements_text":"Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development","official_learning_outcomes_json":"[]"}]